Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4794269
Max Phase: Preclinical
Molecular Formula: C30H27F5N2O5S
Molecular Weight: 622.61
Molecule Type: Unknown
Associated Items:
ID: ALA4794269
Max Phase: Preclinical
Molecular Formula: C30H27F5N2O5S
Molecular Weight: 622.61
Molecule Type: Unknown
Associated Items:
Canonical SMILES: O=C(O)c1ccc(N(Cc2ccc(C3CCCCC3)cc2)C(=O)[C@H]2CCN2S(=O)(=O)c2c(F)c(F)c(F)c(F)c2F)cc1
Standard InChI: InChI=1S/C30H27F5N2O5S/c31-23-24(32)26(34)28(27(35)25(23)33)43(41,42)37-15-14-22(37)29(38)36(21-12-10-20(11-13-21)30(39)40)16-17-6-8-19(9-7-17)18-4-2-1-3-5-18/h6-13,18,22H,1-5,14-16H2,(H,39,40)/t22-/m1/s1
Standard InChI Key: CGWGTLOCBQNRAJ-JOCHJYFZSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 622.61 | Molecular Weight (Monoisotopic): 622.1561 | AlogP: 6.12 | #Rotatable Bonds: 8 |
Polar Surface Area: 94.99 | Molecular Species: ACID | HBA: 4 | HBD: 1 |
#RO5 Violations: 2 | HBA (Lipinski): 7 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 4.14 | CX Basic pKa: | CX LogP: 6.11 | CX LogD: 3.04 |
Aromatic Rings: 3 | Heavy Atoms: 43 | QED Weighted: 0.19 | Np Likeness Score: -1.01 |
1. Brotherton-Pleiss C,Yue P,Zhu Y,Nakamura K,Chen W,Fu W,Kubota C,Chen J,Alonso-Valenteen F,Mikhael S,Medina-Kauwe L,Tius MA,Lopez-Tapia F,Turkson J. (2021) Discovery of Novel Azetidine Amides as Potent Small-Molecule STAT3 Inhibitors., 64 (1.0): [PMID:33352047] [10.1021/acs.jmedchem.0c01705] |
Source(1):